Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
AI Fails to Improve Medical Advice for Real Users
Tech & Innovation AI Fails to Improve Medical Advice for Real Users

Today we’re speaking with Ivan Kairatov, a biopharma expert with a deep understanding of how technology and innovation are reshaping the industry. We'll be exploring the fascinating and complex gap between the theoretical promise of AI in medicine and its real-world performance. The conversation

How Does Brain Compression Trigger Neuron Death?
Research & Development How Does Brain Compression Trigger Neuron Death?

Beyond the malignant cells of a brain tumor lies an equally destructive force, a relentless physical pressure that silently and systematically dismantles the delicate architecture of the mind long before the cancer itself infiltrates surrounding tissue. While medical science has long focused on

Can AI Make Food Safety Testing Flawless?
Tech & Innovation Can AI Make Food Safety Testing Flawless?

As a biopharma expert deeply involved in technological innovation, Ivan Kairatov has been at the forefront of applying advanced science to solve critical industry challenges. Today, he joins us to discuss a groundbreaking development in food safety: an artificial intelligence system that

What's Driving the $47 Billion Whole Body Imaging Boom?
Tech & Innovation What's Driving the $47 Billion Whole Body Imaging Boom?

The landscape of modern medicine is undergoing a profound transformation, shifting from a reactive model of treating symptoms to a proactive strategy focused on early detection and prevention. This evolution is fueling an unprecedented surge in advanced diagnostic technologies, with whole body

How Do PSMA Scans Reshape Prostate Cancer Care?
Research & Development How Do PSMA Scans Reshape Prostate Cancer Care?

For men who have undergone surgery to remove their prostate, a subsequent rise in a key blood marker often signals the cancer's return, plunging them into a period of clinical uncertainty where the next steps have historically been guided more by protocol than precision. This research summary

AI Stethoscope Doubles Detection of Serious Heart Disease
Tech & Innovation AI Stethoscope Doubles Detection of Serious Heart Disease

Today we're speaking with Ivan Kairatov, a biopharma expert with deep insights into the intersection of technology and clinical research. We'll be exploring a groundbreaking study on an AI-powered stethoscope that could fundamentally change how we screen for heart disease. Our discussion will cover

Can Safer mRNA Delivery Unlock a New Era of Medicine?
Biotech & Bioprocessing Can Safer mRNA Delivery Unlock a New Era of Medicine?

The immense success of messenger RNA vaccines painted a tantalizing picture of a medical revolution, yet the very technology that made them possible has also been a barrier to their wider therapeutic use. While transformative in preventing infectious diseases, the first generation of mRNA delivery

Cancer's Sticky Coat Key to Its Deadly Spread
Research & Development Cancer's Sticky Coat Key to Its Deadly Spread

A baffling contradiction has long stood at the heart of understanding how one of the most aggressive forms of breast cancer spreads throughout the body, but new research has finally unraveled this mystery, revealing a unique survival strategy that cancer cells use to become metastatic. For years,

Is a Crypto IPO the Future of Health Tech?
Tech & Innovation Is a Crypto IPO the Future of Health Tech?

The well-trodden path for ambitious tech companies seeking capital and public validation has long been the traditional initial public offering, but a new class of innovators is now charting a course that fuses the rigor of Wall Street with the disruptive potential of Web3. Mexico City-based

Mutation Quality, Not Quantity, Drives Cancer Therapy
Research & Development Mutation Quality, Not Quantity, Drives Cancer Therapy

The promise of harnessing the body's own immune system to fight cancer has been one of the most significant medical breakthroughs of the century, yet a persistent paradox has puzzled clinicians and researchers alike. For years, the prevailing wisdom held that tumors with more genetic mutations were

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later